GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Earnings per Share (Diluted)

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Earnings per Share (Diluted) : ₺1.51 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings per Share (Diluted)?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₺-0.45. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₺1.51.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EPS (Basic) for the three months ended in Dec. 2023 was ₺-0.45. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was ₺1.51.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EPS without NRI for the three months ended in Dec. 2023 was ₺-0.73. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ₺1.33.

During the past 12 months, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's average EPS without NRIGrowth Rate was -36.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 26.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 119.80% per year.

During the past 6 years, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's highest 3-Year average EPS without NRI Growth Rate was 343.00% per year. The lowest was 26.10% per year. And the median was 66.70% per year.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings per Share (Diluted) Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings per Share (Diluted) Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.47 0.69 1.34 2.14 1.51

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 0.35 0.55 1.06 -0.45

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's PE Ratio distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's PE Ratio falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(454.582-0)/300.000
=1.52

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-132.158-0)/300.000
=-0.44

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines